Stock Quote
Rigel Pharmaceuticals Inc (RIGL.W) (NASD ADF)
sector: Healthcare .
industry: Pharmaceuticals - Generic & Specialty ยท
View RIGL on other exchanges
$8.23
23 Nov 2009
+9.59%
$7.51
$8.21
1,800
$8.23
$8.21
$14.75
$4.19
1.76
612,611
RIGL.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Gower, James | Chairman of the Board, Chief Executive Officer | 2,499,330 |
| Maynard, Ryan | Chief Financial Officer, Vice President | 774,148 |
| Rodriguez, Raul | Chief Operating Officer, Executive Vice President | 1,609,880 |
Profile
Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company that discovers and develops small molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. The Company's research focuses on intracellular signaling... Full Description
Company Address
Rigel Pharmaceuticals Inc
1180 Veterans Blvd.
South San Francisco CA 94080
P: +1650.6241100
F: +1650.6241101
1180 Veterans Blvd.
South San Francisco CA 94080
P: +1650.6241100
F: +1650.6241101
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Amgen, Inc. | $56.25 | +0.87 |
| ISIS Pharmaceuticals, Inc. | $11.15 | -0.08 |
| BioCryst Pharmaceuticals, Inc. | $8.90 | -0.65 |
| RIGL.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | -- | 0.57 |
| ROI(TTM) | -82.57 | 1.86 |
| ROE(TTM) | -91.80 | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -0.37 |
| EPS Est. (Current Year) | -2.69 |
| Total Revenue | $0.00M |
| Net Income | $-26.65M |
| EPS | $-0.70 |
